0001553878-15-000019.txt : 20150505 0001553878-15-000019.hdr.sgml : 20150505 20150505173057 ACCESSION NUMBER: 0001553878-15-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150501 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARAGANORE JOHN CENTRAL INDEX KEY: 0001180432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 15834207 MAIL ADDRESS: STREET 1: 75 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-05-01 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001180432 MARAGANORE JOHN C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142 1 1 0 0 Chief Executive Officer Common Stock 122825 D Common Stock 2721 I By Managed Account Stock Option (Right to Buy) 96.45 2015-05-01 4 A 0 75000 0 A 2024-12-17 Common Stock 75000 75000 D The reporting person owns 2,721 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. On December 17, 2014, the Compensation Committee of the Company approved the grant of stock options, at an exercise price of $96.45 per share, to members of its management team, including the Reporting Person. These stock option grants were approved subject to and contingent upon approval by the stockholders of the Company at its 2015 annual meeting of the Amended and Restated 2009 Stock Incentive Plan, to, among other things, increase the shares authorized for issuance thereunder. On May 1, 2015, the stockholders of the Company approved the Amended and Restated 2009 Stock Incentive Plan. The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. /s/ Michael P. Mason, Attorney-in-Fact for: John M. Maraganore 2015-05-05